News > Immune cells present in tumors from head and neck cancer patients, study reports

Immune cells present in tumors from head and neck cancer patients, study reports

A new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the major targets of immune checkpoint inhibitors are present in tumors from head and neck cancer patients.

"We now have an inclination that incorporating immune therapy with PD-1 blockade prior to surgery or radiation may benefit patients," Dr. Mihir Patel of Winship says. "We are actively in the process of developing 'window of opportunity' studies to understand this."